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ICE Family Proteases: Minireview
Mediators of All
Apoptotic Cell Death?
Pierre A. Henkart 1 scheme is consistent with the present data and the
Experimental Immunology Branch hypothesis that cytoplasmic proteases are part of the
National Cancer Institute core molecular apoptotic death pathway. It does not
National Institutes of Health deny the utility of nuclear damage as a readout of apop-
Bethesda, Maryland 20892-1360 totic death nor the possibility that cytoplasmic prote-
ases may enter the nucleus and mediate apoptotic
damage.
The ICE family is defined by sequence homology toIt has become clear that selective lymphocyte death
ICE. Although this enzyme was characterized as theplays a major role in controlling immune responses in
protease that cleaves the inactive precursor of IL-1b toboth B and T cell compartments. The critical death pro-
yield the active cytokine, its possible connection withcesses occur throughout the life of lymphocytes, from
cell death emerged from the cloning of the C. elegansnewly emerging precursor cells to fully mature effector
death gene ced-3 (Yuan et al., 1993). A database homol-cells. Because such cell deaths are generally accompa-
ogy search gave the unanticipated result that humannied by apoptotic features, it is commonly assumed that
ICE was the only homologous sequence to Ced-3. Thethey share a common core of downstream biochemical
more recent evidence that ICE family proteases are partsteps leadingto death, even thoughthe triggering recep-
of a core apoptotic pathway comes largely from studiestors may differ. However, the molecular characterization
of such an apoptotic death pathway has remained elu- showing that inhibitors of these proteases block a wide
sive. Much attention has been focused on understand- range of apoptotic death systems. These deaths appear
ing the molecular function of Bcl-2, which is capable of at least as diverse as those inhibited by the Bcl-2 family,
blocking many diverse apoptotic death systems and but the connections between these two families remain
seems to be related to the product of the nematode cloudy. The depiction in Figure 1 of Bcl-2 acting up-
death antagonist gene ced-9. Bcl-2 is part of a family stream of the proteases is speculative. To appreciate
of related interacting proteins with death-promoting as the biological experiments carried out with inhibitors
well as death-inhibiting properties, but their relation to of ICE family proteases, it is necessary to review the
the molecular pathway of apoptotic death is unclear. background literature on thebiochemisty of these prote-
Recent experiments suggest that a novel family of cyto- ases and the inhibitors themselves.
plasmic proteases related to interleukin-1b (IL-1b)-con- The ICE family proteases are summarized in Figure 2.
verting enzyme (ICE) plays such a core role, which is While more members will be described in the future, the
depicted schematically for thymocytes in Figure 1. The multiplicity of names for individual proteins comes from
purpose of this review is to summarize recent findings their identification in multiple laboratories with different
on thebiochemistry of theseproteases and the evidence approaches, suggesting the family may not be very
for their involvement in programmed cell death. large. The functional properties of family members are
Recognition that physiological cell death in widely now being studied, with some general features and com-
differing biological settings is characterized by a distinct plexities revealed by current data. Among members of
pattern of morphological features led to the introduction this family, only ICE has been studied intensively at the
of the term apoptosis and the concept that such cell protein level, but the homology within the family predicts
death has common features regardless of the trigger general similarities in enzymatic properties. It should be
(Wyllie et al., 1980). The common hallmark property of emphasized that most of these proteases have been
apoptotic death is nuclear damage characterized by cloned from human lymphoid and macrophage cell lines,
chromatin condensation and progressive DNA fragmen- indicating that all have potential relevance to lympho-
tation into an oligonucleosomal ladder. However, the cyte cell death and possibly to other lymphocyte func-
relevance of nuclear damage to cell death has been tions as well.
questioned, since experiments with enucleated cyto- However, theirexpression hasnot beencarefully stud-
plasts indicate that some apoptotic stimuli can ªkillº ied in lymphocyte subpopulations, and Figure 1 should
cytoplasts, as indicated by membrane and mitochon- not be taken to imply that all the ICE family proteases
drial damage (Jacobson et al., 1994; Eischen et al., 1994; are expressed in thymocytes.
Nakajima et al., 1995). These experiments raise the issue
of how cell death is meaningfully measured, since it is
ICE Family Proteases: ICEclear that cells with apoptotic nuclear damage cannot
IL-1b is an important inflammatory factor produced bydivide or transcribe genes. While such cells are clearly
macrophages, and inhibition of its production is a poten-doomed for most biological purposes, their nuclear
tially important therapeutic target. This cytokine is syn-damage may not be part of the normal route to death
thesized as an inactive precursor protein of 31 kDa andas measured by any nonnuclear criteria. If the molecular
subsequently cleaved intracellularly to form the activeapoptotic core events begin upstream, nuclear damage
17 kDa mature IL-1b. When the protease-processingmay represent a side pathway leading to slow death,
enzyme termed ICE was characterized, its sequencewhich is normally preeÈ mpted by a more rapid cyto-
revealed no homology to other proteins, includingplasmic death process (Figure 1). Similarly, apoptotic
known cysteine proteases. Subsequent enzymatic, mu-membrane changes trigger recognition by tissue macro-
phages, leading to phagocytosis and death. The Figure tagenesis, and crystallographic studieshave shown that
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feature may not be found with other ICE family members,
since ICE may participate in IL-1 release from the cell
and analogous functions are not expected.
Studies of the enzymatic specificity of ICE show that it
is highly selective in its proteolytic activity. The principal
requirement for cleavage is an Asp peptide bond (in
protease parlance, Asp is at the P1 position). This speci-
ficity is another hallmark characteristic of the ICE family,
as the serine protease granzyme B of cytotoxic lympho-
cyte granules is the only other mammalian protease
cleavingafter Asp. Additional requirements for substrate
cleavage involve neighboring amino acids. The P19
amino acid following Asp must be small (such as glycine
or alanine); the P2 and P3 residues before Asp can be
variable; hydrophobic amino acids are preferred at the
P4 position. This specificity was determined from a se-
ries of peptide analog substrates based on the physio-Figure 1. A Model for the Role of ICE Family Proteases in the Apop-
logically important IL-1 cleavage, with acetyl-YVAD±Xtotic Death of Thymocytes
emerging as the prototypical synthetic ICE substrate
peptide (Thornberry et al., 1992). The hydrophobic P4
ICE contains a cysteine in its active site, and it is now amino acid appeared to provide important interactions
clear that this protein is the prototype of a new family with the enzyme, since tripeptides were far poorer sub-
of cysteine proteases. The active site cysteine is in a strates. The P4-hydrophobic P1±Asp cleavage prefer-
conserved QACRG motif, which participates in sub- ence makes ICE autoprocessing reasonable, and also
strate binding and catalysis. suggests possible processing of other ICE family mem-
As seen in Figure 2, ICE is synthesized as a precursor bers in a protease cascade. Confirming this, ICE has
molecule of 45 kDa and subsequently processed to form been shown to process and activate pre-CPP32 (Tewari
an active heterodimeric enzyme of 20 kDa and 10 kDa et al., 1995).
chains. Such proteolytic processing is a recurrent gen- The three-dimensional structure of crystalline ICE has
eral theme in protease biochemistry, but this pattern beendetermined (Walker et al.,1995; Wilson et al., 1994),
appears unique to the ICE family. The amino acid se- and provides important insights into the understanding
quences at the four processing cleavage sites are com- of this protein and its homologs. These include elucida-
patible with autoprocessing, and when p45 pre-ICE was tion of the catalytic mechanism of the enzyme, guidance
expressed in COS or baculovirus it was spontaneously for the design of specific enzyme inhibitors, hints as
cleaved to the p20/p10 heterodimer. However, when to the regulation of enzymatic activity, and functional
active site residues are mutated to inactivate catalytic implications of differences between family members.
activity, this autoprocessing is lost (Walker et al., 1995). The most striking finding from crystallographic struc-
In a physiological context, only pre-ICE p45 is detect- tures was that a stable tetramer is formed by dimeriza-
able in resting monocytes, and activation triggers pro- tion of two ICE p20/p10 heterodimer molecules. ICE
teolytic processing to the active species by an unknown heterodimers aggregate in solution and oligomers are
mechanism. While both pre-ICE and processed ICE are required for enzymatic activity and processing, presum-
localized in thecytoplasm, only processed ICE is detect- ably owing to conformational changes accompanying
able on the plasma membrane (Singer et al., 1995). This aggregation. In solution, ICE peptide chains appear
exchangable and, indeed, mixed tetramers can form
between some family members (Gu et al., 1995; Fernan-
des-Alnmeri et al., 1995b). The requirement for ICE ag-
gregation leads to various possibilities for regulation of
its activity, and this property presumably extends to
other members of this protein family.
ICE Family Proteases: CPP32
Except for ICE, more enzymatic data is available for
CPP32 than for other family members. The nuclear DNA
repair enzyme poly[ADP]±ribose polymerase (PARP)
was shown to be cleaved by an ICE-related protease
as part of apoptotic nuclear damage (Lazebnik et al.,
1994). When this enzyme was purified and character-
ized, its sequence corresponded to a previously de-
scribed ICE-related cDNA termed CPP32 (Nicholson et
al., 1995; Fernandes-Alnemri et al., 1994). Expression of
this cDNA gave a recombinant fusion protein, which
cleaved PARP upon processing (Tewari et al., 1995).Figure 2. Properties of ICE Family Proteases
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This cleavage occurs after the sequence DEVD, which in that they recognize DEVD sequences better than
YVAD sequences, but further studies with more sub-differs from sequences recognized by ICE in that the
P4 amino acid is acidic rather than hydrophobic. PARP strates are needed.
cleavage activity is blocked by acetyl-DEVD aldehyde,
while the homologous inhibitor of ICE cleavage, Ac- Functional Assessment of ICE Family Proteases:
YVAD±CHO, was >104-fold less active (Nicholson et al., Induction of Apoptotic Cell Death
1995). This suggests a distinct subtype of ªAsp-aseº While one straightforward approach to probing the func-
specificity that has been used to characterize other ICE tion of molecules is to study the consequences of over-
family members. Compared with ICE, the CPP32 se- expressing them, using cell death as an endpoint raises
quence shows conservation of all the amino acids criti- a number of difficult issues. For example, many insults
cal for catalysis and binding of substrate Asp at the P1 cause cell death, and for most cell types it seems that
position (Nicholson et al., 1995). Pre-CPP32 is pro- any slow death process is apoptotic. Thus, the induction
cessed by ICE (Tewari et al., 1995) and also by granzyme of a cellular apoptotic death response by proteases is
B, with the latter proposed as a critical element in target not necessarily easy to interpret. For example, introduc-
cell killing by cytotoxic lymphocytes (Darmon et al., tion of proteases such as trypsin and chymotrypsin into
1995). the cytoplasm has been shown to trigger apoptotic
death (Williams and Henkart, 1994).
Another potential problem arises from the use of nu-ICE Family Proteases: Ced-3
Ced-3 was characterized in genetic studies as one of clear damage as a readout. From Figure 1, it can be
seen that such damage could reflect an activity that isthe two so-called death genes required for develop-
mental cell death in C. elegans (Horvitz et al., 1994), and not part of the normal cell death effector pathway. This
is particularly an issue in cell-free apoptosis systems,its homology to ICE provided the major link to recogni-
tion of ICE family proteasesas central toapoptotic death which monitor only nuclear damage. Thus, CPP32 is
able to mediate PARP cleavage and induce apoptoticpathways (Yuan et al., 1993). Comparison of Ced-3 and
ICE sequences shows conservation of the amino acids nuclear morphology in the presence of cytosolic ex-
tracts (Nicholson et al., 1995; Schlegel et al., 1996), butknown to participate in catalysis and binding of sub-
strate P1 Asp, leading to the prediction that Ced-3 is unequivocal proof of its involvement in cell death per se
is not easily obtained with other very similar candidatealso an Asp-ase protease. Most of the Ced-3 mutants
that fail to protect against developmental death are proteases present.
A final issue concerns the normal controls over thefound in conserved amino acids likely to be required for
protease activity. Two such mutations occur in the long activation of ICE family proteases, which are widely ex-
pressed as proenzymes. Although they seem to haveCed-3 proline domain and suggest that this is function-
ally important, presumably for control of activation/pro- the ability to autoactivate when experimentally overex-
pressed, in normal cells such activation is suppressedcessing in response to biochemical signaling. The lim-
ited data on the enzymatic properties of Ced-3 show by unknown cellular restraints until death signals are
generated (Duan et al., 1996). If overexpression of anthat it cleaves baculovirus p35 (see below) after the
sequence DQMD; if the latter Asp was mutated to Ala irrelevant ICE family member swamps out a common
restraint system for ICE family protease activation, deathor Glu, cleavage was greatly reduced, indicating a re-
quirement for Asp at P1 (Xue and Horvitz, 1995). may occur because another family member becomes
activated. However, an inactive homolog would be ex-Ced-3 fails to cleave CrmA (see below) after the ICE
motif LVAD, but does so when this is mutated to DQMD; pected to engage the restraint system as well, and if
such a homolog fails to induce death, this objection isCed-3 also cleaves PARP after the sequence DEVD (Xue
and Horvitz, 1995). These data indicate that its specific- unlikely (Lee et al., 1993). In spite of the various limita-
tions on its interpretation, induction of apoptotic cellity is generally similar to CPP32.
death by overexpression has been reported for virtually
all of the ICE family proteases.ICE Family Proteases: Others
Figure 2 is an attempt to summarize several properties
of the various ICE family members. There is considerable Functional Assessment of ICE Family
Proteases: Inhibiting Expressionvariation in the predicted protein precursor size. Assum-
ing that the mature proteases are all ICE-like heterodim- There are limited means to alter one of the ICE family
proteases specifically. One route is via genetic mutation,ers of about 30 kDa, this means that some family mem-
bers have either short or no N-terminal proline domains, as was done for Ced-3. Another is via the gene knockout
approach, which has been done for ICE and undoubt-while the other mammalian family members have prodo-
mains of 10±15 kDa. Sequence dendograms show that edly is underway with others. ICE knockout mice de-
velop normally and have largely normal immune sys-ICE, ICErel-III, and Ich-2 form one branch of this family,
while CPP32, Mch2, and Mch3 form another branch tems, indicating that it is not generally a required
component of apoptotic death. These mice show defi-(Duan et al., 1996).
Limited data is available on the enzymatic properties ciencies in production of inflammatory cytokines from
activated macrophages (Li et al., 1995; Kuida et al.,of other mammalian ICE family proteases and is summa-
rized roughly in Figure 2. Meaningful specificity compari- 1995). Steroids and radiation induce normal levels of
death in thymocytes from such mice, but anti-Fas-in-sons are horizontal rather than vertical in this figure. In
general, it appears most family members are like CPP32 duced death in these cells is impaired (Kuida et al.,
Immunity
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1995). While further studies are needed, these results A critical question for interpretation of experiments in
which cell death is blocked by CrmA expression is whichsuggest that ICE itself is required for Fas-triggered
death, at least in thymocytes. ICE family (or other) proteases are inhibited by CrmA,
and the present data suggest caution in making conclu-Antisense RNA is an alternative method of blocking
mRNA expression particularly suitable to permanent cell sions. Wild-type CrmA is not cleaved by Ced-3 nor does
it block developmental death in C. elegans, while a mu-lines. Such antisense ICH-1/Nedd2-transfected myeloid
tumor clones showed death due to factor withdrawal tant CrmA containing DQMD in place of its LVAD RSL
sequence is cleaved and acquires in vivo cell death±delayed by about 10 hr relative to vector-transfected
controls (Kumar, 1995). These data suggest ICH-1 may blocking activity (Xue and Horvitz, 1995). However, in
the case of CPP32, normal CrmA was shown to complexbe involved in such death but not absolutely required.
with the enzyme and block PARP cleavage both in vitro
and in apoptotic cells (Tewari et al., 1995). In contrastFunctional Asessment of ICE Family Proteases:
with these results, direct measurements of enzymaticEnzymatically Inactive Homologs
activity indicate that CrmA inhibition of CPP32 is 104-Alternatively spliced mRNA forms have been described
fold weaker than its inhibition of ICE (Nicholson et al.,that encode enzymatically inactive variants of ICE, Ich-1,
1995). If CrmA expression blocks death, this could beand Mch-2 (Alnemri et al., 1995; Wang et al., 1994; Fer-
due to its weak interaction with a CPP32-like protease ornandes-Alnemri et al., 1995a). In the former case, two
due to its stronger interaction with an ICE-like proteaseforms were detected by RT±PCR, a d form lacking an
(which might be upstream of CPP32 in a protease cas-exon encoding a region starting near the active site Cys
cade). Strong promoters may well allow sufficient intra-extending into the p10, and an e form encoding only
cellular CrmA levels to allow inhibition by the weakerthe 68 COOH-terminal amino acids. When expressed
interaction.in baculovirus-infected SF9 insect cells, both of these
The case that ICE family proteases play a central func-forms blocked virus-induced death, while enzymatically
tional role in apoptotic cell death rests partly on experi-active ICE forms enhanced death (Alnemri et al., 1995).
ments showing CrmA inhibition of varied examples ofIch-1S describes a mRNA expressed in various tissues
such death. CrmA-transfected rat fibroblasts werethat encodes a shortened Ich-1 form lacking p10 and
shown to be resistant to death induced by serum with-the end of p20. When overexpressed in fibroblasts, this
drawal and by ICE expression, confirming the impor-RNA afforded protection against death by serum with-
tance of protease activity for such cell death (Miura etdrawal (Wang et al., 1994). These experiments suggest
al., 1993). Microinjection of CrmA cDNA into dorsal rootthat enzymatically inactive ICE family proteins can exert
ganglion neurons in vitro led to CrmA protein expressiona dominant negative effect, which could occur during of
and dramatically enhanced cell survival after nerveaggregation of the p20/p10 heterodimers to form active
growth factor withdrawal (Gagliardini et al., 1994). CrmAenzyme. The specificity of these interactions between
cDNA transfection of several tumor lines block tumorthe various members of the ICE family has not yet been
necrosis factor± and anti-Fas-induced apoptotic nuclearclarified. While the physiological importance of the natu-
morphology and death (Tewari and Dixit, 1995; Enari etrally occuring enzymatically inactive homologs is not
al., 1995b; Miura et al., 1995). Similarly, transient trans-clear, they may prove to be a useful experimental tool
fection of mammary epithelial cells with CrmA cDNAto inhibit ICE family proteases.
protected them against apoptotic death induced by re-
moval of extracellular matrix proteins (Boudreau et al.,
Viral Inhibitors of ICE Family Proteases: CrmA 1995).
crmA was originally described as a cowpox gene that
modified host inflammatory responses due to the ability
of its protein product to inhibit ICE (Ray et al., 1992). By Viral Inhibitors of ICE Family Proteases:
Baculovirus p35sequence homology, the CrmA protein is a member of
the serpin family of protease inhibitors, previously The insect baculovirus Autographa californica, in com-
mon with many other viruses, often kills the cells it in-thought to be specific for inhibition of serine proteases,
and CrmA also inhibits the serine protease granzyme B, fects, and dying infected cells show characteristic apop-
totic morphology and DNA fragmentation 3 days afteran Asp-ase from cytotoxic lymphocytes (Quan et al.,
1995). Serpins typically interact with proteases to form viral exposure. Baculovirus appears to induce this death
via a shutdown of host RNA synthesis (Clem and Miller,1:1 complexes that are enzymatically inert, as seen with
ICE and granzyme B (Komiyama et al., 1994; Quan et 1994). Study of a baculovirus mutant virus defective in
replication revealed that it induced apoptotic featuresal., 1995). Serpin proteins contain a reactive site loop
(RSL) that interacts with protease active sites to allow in the host cells within 12 hr, thus aborting the full cycle
of viral replication (Clem et al., 1991). This mutation wasinhibition, and CrmA contains an Asp residue within the
ICE recognition sequence LVAD at the critical RSL site found to be due to a deletion in a previouly described
open reading frame encoding a 35 kDa protein, and(Ray et al., 1992). Thus, CrmA is a specific inhibitor of
ICE family proteases, with expected selectivity for ICE- intentional creation of a mutation in the p35 gene gave
a similar phenotype. The p35 sequence showed no ho-like rather than CPP32-like recognition. As seen with
other serpin±protease interactions, ICE cleaves the RSL mology to other known proteins and was thus proposed
to be a novel class of antiapoptotic proteins that actedof CrmA (Komiyama et al., 1994; Xue and Horvitz, 1995),
but such cleavage is not required for protease inhibition at a different step than Bcl-2 (Clem et al., 1991; Clem
and Miller, 1994).(Gettins et al., 1993).
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Two groups have recently shown that the mechanism The careful use of this approach is illustrated by the
of the ability of baculovirus p35 to block cell death is due demonstration that both YVAD-based ICE inhibitors but
to an inhibition of ICE family proteases. The enzymatic not control inhibitors blockthe in vitro death of motoneu-
activity of purified ICE, Ich-1, Ich-2, and CPP32 were rons induced by several agents, as well as invivo embry-
inhibited by equimolar amounts of recombinant bacu- onic neuronal death (Milligan et al., 1995). In addition,
lovirus p35, and this inhibition is accompanied by a YVAD±CMK blocks anti-Fas-induced death (Enari et al.,
cleavage of p35 to 25 kDa and 10 kDa fragments (Bump 1995b). In contrast, YVAD±CHO failed to block campto-
et al., 1995; Xue and Horvitz, 1995). p35 cleavage occurs thecin-induced death of osteosarcoma cells, which was
at the final Asp of a DQMD sequence, as a mutant lacking blocked by DEVD±CHO (Nicholson et al., 1995). Another
this Asp shows greatly reduced cleavage by Ced-3 or interesting peptide inhibitor is ZVAD±FMK, in which Z
CPP32 (Xue and Horvitz, 1995). The cleaved 10 kDa is a hydrophobic moiety presumably occuping the ICE
amino-terminal fragment of p35 forms a stable complex P4 pocket. The Asp residue in this reagent is esterified
with ICE, inactivating it (Bump et al., 1995). The ability to promote membrane permeability, but this ester is
of p35 to block other classes of proteases has not been presumably removed by intracellular esterases. It was
extensively reported, but unlike crmA, it does not inhibit shown to block apoptotic nuclear damage in thymo-
the serine protease granzyme B (Bump et al., 1995). cytes induced by etoposide, thapsigargin, and dexa-
Without further experiments with other proteases there methasone (Fearnhead et al., 1995), and similar damage
must be some reservations about an interpretation that in monocytic cells induced by cycloheximide, thapsigar-
the biological effects of p35 are due to its ability to gin, etoposide, and staurosporine (Zhu et al., 1995).
inhibit ICE family proteases, although the existing data Blocking of apoptotic cell death by other reagents based
suggest a specific interaction. on Asp alone may also be due to reaction with ICE family
It is clear that baculovirus p35 has a very broad ability proteases (Mashima et al., 1995; Boudreau et al., 1995),
to prevent apoptotic cell death beyond that seen in ba- but the specificity of these reagents is open to question.
culovirus infections. For example, C. elegans develop-
mental death is blocked by transgenic baculovirus p35
expression under a heat shock promoter (Sugimoto et Failure of ICE Family Protease Inhibitors
al., 1994), and this effect is nullified by the mutant that to Block Cell Death
is not recognized by Ced-3 (Xue and Horvitz, 1995). Two examples of apoptotic cell death that is not blocked
Transgenic Drosophila expressing p35 with this pro- by inhibitors of ICE-like proteases have been reported.
moter showed fewer embryonic cell deaths, and a tis- IL-2 withdrawal-induced death and DNA fragmentation
sue-specific promoter used to show that later develop-
in murine CTLL-2 cells was not blocked by two different
mental cell death during eye differentiation also inhibited
AcYVAD±peptide inhibitors, even though these inhibi-
by p35 expression (Hay et al., 1994). Radiation-induced
tors blocked IL-1b production and Fas-mediated apop-
death in these developing eyes was also blocked. In
totic death in other murine cells (Vasilakos et al., 1995).mammalian systems, a neuronal cell line transfected
Other inhibitors of ICE family proteases were not testedwith p35 cDNA was protected against death by serum
in this report, nor were other IL-2-dependent cells.withdrawal and calcium ionophore (Rabizadeh et al.,
In a murine T cell hybridoma, expression of CrmA1993), and a p35-transfected breast tumor line was re-
inhibited Fas-mediated death but not that induced bysistant to death induced by tumor necrosis factor and
dexamethasone (Memon et al., 1995). It would be inter-anti-Fas (Smith et al., 1994). These biological effects of
esting to know whether inhibitors based on DEVD recog-baculovirus p35 are powerful evidence that ICE family
nition block the steroid-induced death of these cells.proteases are general mediators of apoptotic cell death.
These results suggest that within a single cell different
apoptotic stimuli can utilize different members of thePeptide-Based Inhibitors of ICE Family Proteases
ICE family, as also suggested by the ICE knockout thy-Protease inhibitors that can be added to cells in vitro
mocytes.and in vivo have obvious advantages in that they can
be applied without transfection or creation of transgenic
animals. However, their specificity is open to question,
Conclusionsand most general cysteine protease inhibitors are very
As outlined above, inhibitors of ICE family proteasestoxic to cells. More specific protease inhibitors based
are capable of blocking apoptotic death triggered byon the optimal ICE peptide substrate YVAD and CPP32
diverse signals in different cell types, both in vitro andsubstrate DEVD have been developed by modifying the
in vivo. These include nematode, insect, avian, andterminal carboxylic acid to aldehyde and chloromethyl
mammalian systems, and tissue types ranging from neu-ketone groups. These inhibitors block some but not all
ronal and lymphoid cells to fibroblasts and various tu-cell-free apoptosis models in which apoptotic cyto-
mors. While the specificity of any one inhibitor can beplasm induces apoptotic nuclear changes (Lazebnik et
challenged, the combined data using different ap-al., 1994; Nicholson et al., 1995; Enari et al., 1995a). In
proaches and reagents is impressive in making a caseintact cells, their use is limited by membrane imperme-
that the ICE protease family plays a central shared func-ability, but use of high micromolar extracellular concen-
tional role in apoptotic death pathways. The few re-trations appears effective in blocking some cell death
ported cases of apoptotic death that are resistant tosystems. To make a convincing case that these inhibi-
these inhibitors may involve protease inhibitors that in-tors are acting via blocking ICE family proteases, con-
hibit some family members selectively. Because cellstrols need to be carried out with homologous but non-
Asp-containing inhibitors. are complex biochemical systems vulnerable to failure
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Gettins, P., Patston, P.A., and Schapira, M. (1993). Bioessays 15,at many points, it may well be that some cases of pro-
461±467.grammed cell death are not mediated by ICE family
Gu, Y., Wu, J., Faucheu, C., Lalanne, J.-L., Diu, A., Livingston, D.J.,proteases. However, the current literature on use of the
and Su, M.S.-S. (1995). EMBO J. 14, 1923±1931.inhibitors reviewed above suggests that their ability to
Hay, B.A., Wolff, T., and Rubin, G.M. (1994). Development 120, 2121±block cell death systems is at least as wide-ranging as
2129.that of Bcl-2 and its family members.
Horvitz, H.R., Shaham, S., and Hengartner, M.O. (1994). Cold SpringMany important issues remain regarding the details
Harbor Symp. Quant. Biol. 59, 377±386.of how the activation of ICE family proteases leads to
Jacobson, M.D., Burne, J.F., and Raff, M.C. (1994). EMBO J. 13,death. These include the relative importance of different
1899±1910.
ICE family members in different tissues, their enzymatic
Komiyama, T., Ray, C.A., Pickup, D.J., Howard, A.D., Thornberry,specificity and physiologically important substrates, the
N.A., Peterson, E.P., and Salvesen, G. (1994). J. Biol. Chem. 269,
extent to which they are part of a protease cascade or 19331±19337.
in parallel pathways, and the mechanism of their activa- Kuida, K., Lippke, J.A., Ku, G., Harding, M.W., Livingston, D.J., Su,
tion. Nevertheless, the current data argue that ICE family M.S.-S., and Flavell, R.A. (1995). Science 267, 2000±2003.
proteases in some combination are part of a common Kumar, S. (1995). FEBS Lett. 368, 69±72.
core death pathway for apoptotic cell death. While there Lazebnik, Y.A., Kaufmann, S.H., Desnoyers, S., Poirier, G.G., and
are closed boxes in Figure 1 representing unknown ele- Earnshaw, W.C. (1994). Nature 371, 346±347.
ments in this core pathway, the major point of this model Lee, M.-R., Liou,M.-L., Yang, Y.-F., and Lai, M.-Z. (1993). J. Immunol.
is to show various distinct input pathways leading to a 151, 5208±5217.
common core involving activation of ICE family prote- Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C.,
ases. The proteases can then act on a number of down- McDowell, J., Paskind, M., Rodman, L., Salfeld, J., Towne, E., Tra-
cey, D., Wardwell, S., Wei, F.-Y., Wong, W., Kamen, R., and Seshadri,stream elements leading to multiple damage pathways.
T. (1995). Cell 80, 401±412.In different circumstances, one or the other of these
Mashima, T., Naito, M., Kataoka, S., Kawai, H., and Tsuruo, T. (1995).damage pathways can lead to cell death. The coming
Biochem. Biophys. Res. Comm. 209, 907±915.years should see experiments carried out in many labo-
Memon, S.A., Moreno, M.B., Petrak, D., and Zacharchuk, C.M.ratories that will test the validity of this scheme.
(1995). J. Immunol. 155, 4644±4652.
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